Executive Summary: Middle East & Africa Oxygen Therapy Market Size, Trends & Forecasts (2026–2034)

Market Scope: Comprehensive regional analysis of the Middle East and Africa oxygen therapy market covering product types, clinical applications, end-user settings, and country-level developments across the GCC, Levant, and African nations.
Market Valuation: The Middle East and Africa oxygen therapy market size was valued at USD 0.20 billion in 2025, estimated at USD 0.21 billion in 2026, and is anticipated to reach USD 0.24 billion by 2034, growing at a CAGR of 5.66% during the forecast period from 2026 to 2034.
Primary Growth Drivers & Mechanics: Propelled by rising tobacco consumption, increasing prevalence of chronic respiratory illnesses (such as COPD and asthma), a growing geriatric population requiring long-term home care, and constant technological advancements in therapy equipment, counterbalanced by strict regulatory standards and reimbursement cuts.

Middle East & Africa Oxygen Therapy Market Segment Metrics (2026–2034)

Category	Leading Segment / Key Focus (2025 Position)	Growth Dynamics / High-Growth Areas
By Product Type	Oxygen Source Equipment (anchored by a strong preference for standalone oxygen concentrators and cylinders)	Oxygen Delivery Devices (nasal cannulas and specialized masks expanding rapidly with patient preference)
By Application	Chronic Obstructive Pulmonary Disease (COPD) (primary driver for long-term palliative care demand)	Asthma & Obstructive Sleep Apnea (growing segments among urban demographics)
By End-User	Home Healthcare (experiencing robust adoption driven by elderly care needs and preference for at-home management)	Hospitals & Specialty Clinics (critical infrastructure maintaining acute care standards)
By Country / Region	United Arab Emirates (UAE) (leading MEA market share driven by advanced healthcare infrastructure and high COPD prevalence)	KSA, Israel, and South Africa (expanding via modernized health facilities and government initiatives)

Major Market Players & Industry Structure

Market Structure: Fragmented competitive environment featuring international medical device corporations collaborating with local distributors to navigate complex regional regulatory frameworks and supply chain hurdles.

Key Companies: Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., and Respan Products Inc.

Middle East and Africa Oxygen Therapy Market Size

The Middle East and Africa Oxygen Therapy Market size was valued at USD 0.20 billion in 2025 and is anticipated to reach USD 0.21 billion in 2026 from USD 0.24 billion by 2034, growing at a CAGR of 5.66% during the forecast period from 2026 to 2034.

An increase in tobacco consumption and the prevalence of respiratory illnesses, a preference for standalone oxygen therapy devices over portable oxygen therapy devices, and constant technological improvements in the field of oxygen therapy are primarily driving the growth of the oxygen therapy market in the Middle East and Africa.

Oxygen therapy is often utilized to treat various respiratory illnesses due to its beneficial palliative and supplementary role. Furthermore, the development of efficient and advanced technology and a rapidly aging population at risk of developing respiratory diseases are further predicted to favor the oxygen therapy market in the MEA region to register a steady growth during the forecast period.

The rise in the usage of standalone oxygen therapy devices has been attributed to an increase in cigarette smoking, the prevalence of respiratory disorders, and a preference for freestanding oxygen therapy devices over inhalers. Furthermore, continuous technological advancements in oxygen therapy and portable oxygen therapy equipment are also expected to accelerate the adoption of oxygen therapy in this region. In addition, the increased number of people suffering from respiratory diseases is expected to drive market expansion.

However, strict regulatory rules may cause delays in the clearance of oxygen therapy equipment, limiting the market's growth. The expansion of the market is further anticipated to be stymied by the availability of low-cost competitors from local manufacturers, strict regulatory standards that cause delays in product approvals, and Medicare reimbursement rate cuts for home oxygen treatment in the United Arab Emirates. The market growth in the Middle East and Africa is also projected to be suffocated by a cumbersome regulatory environment. The absence of developed infrastructure in emerging nations that would allow for at-home treatment is another aspect that is predicted to pose a challenge to the MEA market.

REGIONAL ANALYSIS

The oxygen therapy market in the Middle East and Africa is predicted to account for a moderate share in the global market during the forecast period. The growing need for at-home care among the elderly, the well-developed healthcare infrastructure that supports modern healthcare institutions, and the presence of significant players in the Middle East and Africa, such as Kuwait and the United Arab Emirates, all contribute to the region's supremacy.

The United Arab Emirates is expected to lead the MEA market due to increasing COPD cases among its residents. In addition, technical improvements, improved infrastructure, equipment, and a high level of knowledge about the availability of therapy for various chronic respiratory ailments are projected to drive the market during the forecast period.

KEY MARKET PLAYERS

Companies are playing an essential role in the MEA Oxygen Therapy Market include

Chart Industries Inc.
Invacare Corporation
Becton, Dickinson and Company
Smiths Medical
Teleflex Incorporated
Inogen, Inc.
DeVilbiss Healthcare
Essex Industries, Inc.
Allied Healthcare Products Inc.
Respan Products Inc.

MARKET SEGMENTATION

This research report on the Middle East and Africa oxygen therapy market has been segmented & sub-segmented into the following categories

By Product Type

Oxygen Source Equipment
- Oxygen Concentrators
  - Fixed Oxygen Concentrators
  - Portable Oxygen Concentrators
- Liquid Oxygen Devices
- Oxygen Cylinders
Oxygen Delivery Devices
- Oxygen Masks
- Nasal Cannulas
- Venturi Masks
- Non-Rebreather Masks
- Bag Valve Masks
- Other Devices

By Application

Chronic Obstructive Pulmonary Disease
Asthma
Obstructive Sleep Apnea
Respiratory Distress Syndrome
Cystic Fibrosis
Pneumonia

By End-user

Home Healthcare
Hospitals

By Country

KSA
UAE
Israel
rest of GCC countries
South Africa
Ethiopia
Kenya
Egypt
Sudan
rest of MEA

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Middle East and Africa Oxygen Therapy Market Report